Characterization of BK polyomavirus-associated nephropathy (BKPyVAN) in kidney transplant recipients using transcriptomic analysis: a comprehensive scoping review
Pathogens and Disease · 2025
DOI: 10.1093/femspd/ftaf006 ↗Kurz gefasst
Scoping Review in der Zeitschrift Pathogens and Disease, 2025. Verfasst von Lachlan A Davidson und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW 2308, Australia. Hauptthemen laut MEDLINE: Polyomavirus Infections, Kidney Transplantation, BK Virus, Gene Expression Profiling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Training Program- Australian Goverment.
Abstract (Originalsprache)
BK polyomavirus (BKPyV) infection reactivates with immunosuppressive therapies and can lead to the development of BKPyV-associated nephropathy (BKPyVAN) in kidney transplant recipients. This scoping review assesses the use of transcriptomics to profile BKPyVAN in kidney transplant recipients. The following search strategy was employed in Medline and Embase: ‘BK virus’ or ‘BK polyomavirus’ or ‘Polyomavirus’ AND ‘Kidney transplant’ or ‘Nephritis’ or ‘Nephropathy’ AND ‘Gene expression’ or ‘Transcriptomics’ or ‘mRNA’. The search identified 368 publications (264 EMBASE and 104 MEDLINE), and after removal of duplicates (92) and abstract/full-text screening, there were 11 eligible studies which included 7 original transcriptomic studies and 4 bioinformatic studies. There was consistent dysregulated expression of proinflammatory pathways (e.g. cytokines, chemokines, T- and B-cell-related pathways) in BKPyVAN compared with stable graft function. There was considerable overlap between the gene expression patterns identified in BKPyVAN and T-cell mediated rejection that require more exploration. This review highlights limitations including small sample sizes, lack of validation, and variation in technical platforms and study designs. Transcriptomics in BKPyVAN is currently underutilized and there is a genuine need for further research in larger cohorts to provide action in discovering novel therapeutic targets and discriminative gene expression signatures to guide individualized therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW 2308, Australia.
- Immune Health Research Programme, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.
- Hunter Transplant Research Foundation, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia.
- Newcastle Renal Transplant Unit, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia.
ORCID-Profile: Lachlan A Davidson
Förderung
- Research Training Program- Australian Goverment
Zitieren
APA
Davidson, L. A., Niessen, N. M., Rowlandson, M., Myint, T. M., Trevillian, P. R., Hibberd, A. D., Heer, M. K., Horvat, J. C., & Baines, K. J. (2025). Characterization of BK polyomavirus-associated nephropathy (BKPyVAN) in kidney transplant recipients using transcriptomic analysis: a comprehensive scoping review. Pathogens and Disease. https://doi.org/10.1093/femspd/ftaf006
Vancouver
Davidson LA, Niessen NM, Rowlandson M, Myint TM, Trevillian PR, Hibberd AD, et al. Characterization of BK polyomavirus-associated nephropathy (BKPyVAN) in kidney transplant recipients using transcriptomic analysis: a comprehensive scoping review. Pathogens and Disease. 2025. doi:10.1093/femspd/ftaf006
BibTeX
@article{Davidson2025,
author = {Davidson, Lachlan A and Niessen, Natalie M and Rowlandson, Matthew and Myint, Thida M and Trevillian, Paul R and Hibberd, Adrian D and Heer, Munish K and Horvat, Jay C and Baines, Katherine J},
title = {Characterization of BK polyomavirus-associated nephropathy (BKPyVAN) in kidney transplant recipients using transcriptomic analysis: a comprehensive scoping review},
journal = {Pathogens and Disease},
year = {2025},
doi = {10.1093/femspd/ftaf006}
}
EUVIMED